Publications by authors named "Russell Jenkins"

Claim this Profile
T
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular Immunotherapy.
Eric P Grewal, Samuel J Steuart, Baolin Liu, Hongyan Xie, Derek N Effiom, Russell W Jenkins

Neuro Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the preparation and analysis of patient-derived organotypic tumor spheroids.
Claire A Palin, Russell W Jenkins, Or-Yam Revach

STAR Protoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity.
Taral R Lunavat, Lisa Nieland, Sanne M van de Looij, Alexandra J E M de Reus, Charles P Couturier, Russell W Jenkins

Mol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease.
Cameron A Beard, Kyra N Hermanson, Justin M Snider, Aki Hara, Brandon K Dahl, Russell W Jenkins

Neurobiol Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8 TIL.
Hongyan Xie, Aiping Jiang, Aonkon Dey, Joseph W Dean, Jonathan J Perera, Russell W Jenkins

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is Upregulated by IFNy Signaling.
Martin Q Rasmussen, Marie L Bønnelykke-Behrndtz, Camilla Merrild, Ida Tvilling, Julie N Christensen, Russell W Jenkins

Pigment Cell Melanoma Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of a potent interleukin-21 mimic for cancer immunotherapy.
Jung-Ho Chun, Birkley S Lim, Suyasha Roy, Michael J Walsh, Gita C Abhiraman, Russell W Jenkins

Sci Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for targeting TBK1 in CAR-T cell therapies for cancer.
Giulia Cattaneo, Marco Ventin, Luke Maggs, Yi Sun, Cristina R Ferrone, Russell W Jenkins

Expert Opin Ther Targets· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants.
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, Claire A Palin, Boryana Petrova, Russell W Jenkins

Cell Rep Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and analysis of monotypic and organotypic tumor spheroids.
Ana Carolina M Domingues, Claire Palin, Yi Sun, Hongyan Xie, Elliot C Woods, Russell W Jenkins

Methods Cell Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived organotypic tumor spheroids, tumoroids, and organoids: advancing immunotherapy using state-of-the-art 3D tumor model systems.
David J Bozym, David X Zheng, Or-Yam Revach, Amir Aref, Russell W Jenkins

Lab Chip· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy.
Ryan J Sullivan, Anthony R Cillo, Robert L Ferris, Russell W Jenkins, Harriet M Kluger

J Immunother Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.
Rishab Ramapriyan, Fred G Barker, Leland G Richardson, Jing Sun, Gust Vandecandelaere, Russell W Jenkins

Neuro Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosis.
Jooho Chung, Mounica Vallurupalli, Sarah Noel, Gail Schor, YuhJong Liu, Russell W Jenkins

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance-Use Disorders in Critically Ill Patients: A Narrative Review.
Rebecca Piland, Russell Jack Jenkins, Dana Darwish, Bridgette Kram, Kunal Karamchandani

Anesth Analg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade.
Ana Carolina M Domingues, Soraia B de Oliveira, Nayara G Tessarollo, Ana Paula Lepique, Otavio Rodrigues, Russell W Jenkins

Mol Ther Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J Wright, Angelina M Cicerchia, Russell W Jenkins

Cancer Immunol Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanical signatures in cancer metastasis.
Ayushi Agrawal, Yousef Javanmardi, Sara A Watson, Bianca Serwinski, Boris Djordjevic, Russell W Jenkins

NPJ Biol Phys Mech· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity.
Taral R Lunavat, Lisa Nieland, Sanne M van de Looij, Alexandra J E M de Reus, Charles P Couturier, Russell W Jenkins

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data confirms limited efficacy of dual programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 immune checkpoint blockade in acral lentiginous melanoma.
David X Zheng, Russell W Jenkins

Br J Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Resistance Mechanisms to Melanoma Immunotherapy.
David X Zheng, David J Bozym, Giuseppe Tarantino, Ryan J Sullivan, David Liu, Russell W Jenkins

Am J Clin Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent antitumor activity of a designed interleukin-21 mimic.
Jung-Ho Chun, Birkley S Lim, Suyasha Roy, Michael J Walsh, Gita C Abhiraman, Russell W Jenkins

bioRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial.
Meghan J Mooradian, Florian J Fintelmann, Thomas J LaSalle, Judit Simon, Alexander Graur, Russell W Jenkins

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.
Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, Lei Shi, Yi Xiao, Russell W Jenkins

Science· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis